 |
 |

Follow-up Testing Among Children With Elevated Screening Blood Lead Levels
Alex R. Kemper, MD, MPH, MS;
Lisa M. Cohn, MS;
Kathryn E. Fant, MPH;
Kevin J. Dombkowski, DrPH;
Sharon R. Hudson, RN, MSN, CNM
JAMA. 2005;293:2232-2237.
Context Follow-up testing after an abnormal screening blood lead level is a key component of lead poisoning prevention.
Objectives To measure the proportion of children with elevated screening lead levels who have follow-up testing and to determine factors associated with such care.
Design, Setting, and Participants Retrospective, observational cohort study of 3682 Michigan Medicaid-enrolled children aged 6 years or younger who had a screening blood lead level of at least 10 µg/dL (0.48 µmol/L) between January 1, 2002, and June 30, 2003.
Main Outcome Measure Testing within 180 days of an elevated screening lead level.
Results Follow-up testing was received by 53.9% (95% confidence interval [CI], 52.2%-55.5%) of the children. In multivariate analysis adjusting for age, screening blood lead level results, and local health department catchment area, the relative risk of follow-up testing was lower for Hispanic or nonwhite children than for white children (0.91; 95% CI, 0.87-0.94), for children living in urban compared with rural areas (0.92; 95% CI, 0.89-0.96), and for children living in high- compared with low-risk lead areas (0.94; 95% CI, 0.92-0.96). Among children who did not have follow-up testing, 58.6% (95% CI, 56.3%-61.0%) had at least 1 medical encounter in the 6-month period after the elevated screening blood lead level, including encounters for evaluation and management (39.3%; 95% CI, 36.9%-41.6%) or preventive care (13.2%; 95% CI, 11.6%-14.8%).
Conclusions The rate of follow-up testing after an abnormal screening blood lead level was low, and children with increased likelihood of lead poisoning were less likely to receive follow-up testing. At least half of the children had a missed opportunity for follow-up testing. The observed disparities of care may increase the burden of cognitive impairment among at-risk children.
Author Affiliations: Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor (Drs Kemper and Dombkowski and Mss Cohn and Fant); and Childhood Lead Poisoning Prevention Program, Michigan Department of Community Health, Lansing (Ms Hudson).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLES
Childhood Lead Poisoning Prevention: Too Little, Too Late
Bruce P. Lanphear
JAMA. 2005;293(18):2274-2276.
EXTRACT
| FULL TEXT
Lead Poisoning
Sarah Ringold, Cassio Lynm, and Richard M. Glass
JAMA. 2005;293(18):2304.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Can We Turn a Toxin Into a Tonic? Toward 21st-Century Television Alchemy
Christakis
Pediatrics 2007;120:647-648.
FULL TEXT
Primary Care Physicians' Attitudes Regarding Follow-up Care for Children With Positive Newborn Screening Results
Kemper et al.
Pediatrics 2006;118:1836-1841.
ABSTRACT
| FULL TEXT
Lead Poisoning: Successes and 21st Century Challenges
Laraque and Trasande
Pediatr. Rev. 2005;26:435-443.
FULL TEXT
Follow-Up of Elevated Screening Blood Lead Levels
Aldous
AAP Grand Rounds 2005;14:44-45.
FULL TEXT
Children with elevated lead levels receive poor follow-up care
Kemp
AAP News 2005;26:2-2.
FULL TEXT
What's new in the other general journals
Tonks
BMJ 2005;330:1171-1172.
FULL TEXT
Childhood Lead Poisoning Prevention: Too Little, Too Late
Lanphear
JAMA 2005;293:2274-2276.
FULL TEXT
|